ALPS Advisors’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
PFA
YIH
MAP
KPWS
PFSRSONJ
TWC
SO
KWA
BRG
ALPS Advisors's DFTX Position: Q2 2026 in Review
ALPS Advisors opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 110,388 shares worth $5.19M. The stake represents 0.02% of the portfolio and ranks #273 among its holdings.
69 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.
- ALPS Advisors held 110,388 shares of Definium Therapeutics worth $5.19M as of Q2 2026.
- Definium Therapeutics was a new ALPS Advisors position in Q2 2026.
- Definium Therapeutics made up 0.02% of ALPS Advisors's portfolio in Q2 2026, its #273 holding.
- 69 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.
Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.